MedTrace Logo

Surgical Approach for Retrorectal Tumors Cohort

NCT04757103 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2021-11-15

No results posted yet for this study

Summary

Aim of the study :

To evaluate postoperative outcomes of all surgical approach for retrorectal tumors.

Methods :

From 2005 to 2020, all consecutive patients who underwent surgery for a retrorectal tumor in two referral tertiary center were prospectively collected.

Considering our exlusion criterias, data from XX patients were analyzed. The cohort was separated into 2 groups according to tumor localization regarding the third sacral vertebra.

Short and longterm outcomes were compared between the two groups.

Primary outcome :

90 days postoperative morbidity rate

Conditions

  • Malignant Tumor

Interventions

PROCEDURE

Resection of the retrorectal tumor

Surgical resection of the retrorectal mass

Sponsors & Collaborators

  • Université Montpellier

    collaborator OTHER

  • Centre Hospitalier Universitaire de Nīmes

    collaborator OTHER

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Thomas Bardol · University Hospital, Montpellier

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2021-01-30
Completion
2021-05-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04757103 on ClinicalTrials.gov